Beyond the clinic: Can digital therapeutics (DTx) help boost mental health in the workforce at scale?

By SharpBrains | October 2, 2023

Hop­ing to Avoid Pear’s Fate, Behav­ioral Health-Focused DTx Com­pa­nies Look to Employ­er Mar­ket (Behav­ioral Health Busi­ness): The dig­i­tal ther­a­peu­tics (DTx) indus­try is at a cross­roads after one of the most promi­nent com­pa­nies in the space, Pear Ther­a­peu­tics, filed for bank­rupt­cy ear­li­er this year. The tur­moil comes after DTx began catch­ing on in the behav­ioral health…

Read More

Four reasons to question “new generation” monoclonal antibody Alzheimer’s drugs such as aducanumab (Aduhelm), lecanemab (Leqembi), donanemab

By SharpBrains | September 25, 2023

New Alzheimer’s Drugs Don’t Deserve the Hype (Being Patient): A promi­nent child­hood mem­o­ry is of my grand­par­ents liv­ing with and then dying from demen­tia. As is uni­ver­sal with demen­tia, there was a dou­ble blow: watch­ing my grand­par­ents lose their iden­ti­ty and see­ing the suf­fer­ing of those clos­est to them.

Read More

“To do nothing is not an option”: The NHS Confederation releases digital mental health whitepaper

By SharpBrains | September 12, 2023

The NHS Con­fed­er­a­tion–the mem­ber­ship organ­i­sa­tion for health­care providers in Eng­land, Wales and North­ern Ire­land– has just released a quite com­pre­hen­site 45-page whitepa­per titled Max­imis­ing the poten­tial of dig­i­tal in men­tal health. Some of the high­lights: To do noth­ing is not an option. If we don’t make more progress we miss a key oppor­tu­ni­ty to make…

Read More

Next: Harnessing Neuroplasticity, Medication AND Psychotherapy to treat mental health conditions

By The Conversation | September 6, 2023 |

There is mount­ing recog­ni­tion in the sci­en­tif­ic com­mu­ni­ty that com­bin­ing dif­fer­ent treat­ment approach­es for men­tal health con­di­tions can cre­ate a ben­e­fit greater than the sum of its parts. As a clin­i­cal psy­chol­o­gist and neu­ro­science researcher, I have been work­ing to inte­grate insights from both fields to expand treat­ment options for those suf­fer­ing from depres­sion, anx­i­ety and…

Read More

Time for a universal “exercise prescription” for kids and adults to boost cognition and mental health?

By SharpBrains | August 31, 2023 |

Wel­come to a new edi­tion of Sharp­Brains e‑newsletter, fea­tur­ing this time a range of brain research find­ings, tools and con­tro­ver­sies plus some brain teasers to chal­lenge your (and our) work­ing mem­o­ry. #1. Major evi­dence review sup­ports an “exer­cise pre­scrip­tion” for most adults to boost men­tal health “High­er inten­si­ty phys­i­cal activ­i­ty was asso­ci­at­ed with greater improvements”…

Read More

Evidence review: Physical exercise helps boost attention, cognitive flexibility and inhibitory control in children and adolescents with ADHD

By Dr. David Rabiner | August 23, 2023 |

The impact of phys­i­cal exer­cise on ADHD has been exam­ined in a large num­ber of stud­ies. Col­lec­tive­ly, these stud­ies have exam­ined whether exer­cise reduces on core ADHD symp­toms, e.g., inat­ten­tion and hyperactivity/impulsivity, and strength­ens exec­u­tive func­tions, e.g., inhibito­ry con­trol, work­ing mem­o­ry, and men­tal health, e.g., emo­tion­al and social func­tion­ing. Over­all, results across mul­ti­ple stud­ies suggest…

Read More